Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -9 of 9
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/14/2009
 
First Published:
6/23/2003
1.
Phase III Randomized Study of Interstitial Brachytherapy With or Without External Beam Radiotherapy in Patients With Intermediate-Risk Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
RTOG-0232
CTSU, NCT00063882
Last Modified:
1/10/2009
 
First Published:
3/24/2005
2.
Phase III Randomized Study of Sublobar Resection With Versus Without Intraoperative Brachytherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
NCI
ACOSOG-Z4032
SRCI, NCT00107172
3.
I-125 Versus Pd-103 for Medium Risk Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
40 to 90
Other
02-4407-V04
NCT00486499
Last Modified:
9/15/2008
 
First Published:
4/21/2008
4.
Phase III Randomized Study of Neoadjuvant Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy and Permanent Iodine I 125 Implantation With Versus Without Adjuvant LHRH Agonist Therapy in Patients With Previously Untreated Intermediate-Risk Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
20 to 75
Other
JUSMH-BRI-GU05-01
BRI_GU05-01, NCT00664456
5.
Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Supportive care, Treatment
Active
50 and over
Other
IRB 8488
CASE16804, NCT00252941
Last Modified:
1/8/2009
 
First Published:
3/16/2007
6.
Phase II Study of Transperineal Ultrasound-Guided Iodine I 125 or Palladium Pd 103 Brachytherapy in Patients With Locally Recurrent Adenocarcinoma of the Prostate Previously Treated With External-Beam Radiotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
NCI
RTOG-0526
NCT00450411
7.
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Active
18 and over
Other
NA-15-0003
NCT00126854
First Published:
9/18/2007
8.
Study of Brachytherapy With Iodine I-125 in Patients With Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
Any age
Other
TUSM-BRI-GU-04-01
BRI GU 04-01, NCT00534196
9.
Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Active
Over 18
Other
CCR3047
NCT00749697
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute